Zobrazeno 1 - 10
of 1 767
pro vyhledávání: '"Turcq, B"'
Autor:
Lézine, A.-M., Turcq, B., Desjardins, T., Mandeng-Yogo, M., Cetin, F., Tchiengué, B., Achoundong, G.
Publikováno v:
In Review of Palaeobotany and Palynology January 2025 332
Autor:
Catrain, M., Lézine, A.-M., Turcq, B., Desjardins, T., Mandeng-Yogo, M., Cetin, F., Achoundong, G.
Publikováno v:
In Review of Palaeobotany and Palynology June 2023 313
Autor:
Martins, G.S., Cordeiro, R.C., Turcq, B., Meyers, P.A., Mendez-Millan, M., Moreira, L.S., Fontes, D., Rodrigues, R.A., Sifeddine, A., Behling, H., Bouloubassi, I.D.
Publikováno v:
In Global and Planetary Change June 2022 213
Autor:
Amintas S; Bordeaux Institute in Oncology - BRIC - BioGo team, Univ. Bordeaux, INSERM U1312, Bordeaux, France. samuel.amintas@u-bordeaux.fr.; Department of Tumor Biology and Tumor Library, CHU Bordeaux, Bordeaux, France. samuel.amintas@u-bordeaux.fr., Cullot G; Bordeaux Institute in Oncology - BRIC - MoTRIL team, Univ. Bordeaux, INSERM U1312, Bordeaux, France.; Department of Biology, ETH Zurich, Zurich, Switzerland., Boubaddi M; Bordeaux Institute in Oncology - BRIC - BioGo team, Univ. Bordeaux, INSERM U1312, Bordeaux, France.; Department of Digestive Surgery, CHU Bordeaux, Bordeaux, France., Rébillard J; Bordeaux Institute in Oncology - BRIC - BioGo team, Univ. Bordeaux, INSERM U1312, Bordeaux, France., Karembe L; Bordeaux Institute in Oncology - BRIC - BioGo team, Univ. Bordeaux, INSERM U1312, Bordeaux, France., Turcq B; Bordeaux Institute in Oncology - BRIC - MoTRIL team, Univ. Bordeaux, INSERM U1312, Bordeaux, France.; CRISP'edit, TBMCore, CNRS UAR3427, INSERM US005, Bordeaux, France., Prouzet-Mauléon V; Bordeaux Institute in Oncology - BRIC - MoTRIL team, Univ. Bordeaux, INSERM U1312, Bordeaux, France.; CRISP'edit, TBMCore, CNRS UAR3427, INSERM US005, Bordeaux, France., Bedel A; Bordeaux Institute in Oncology - BRIC - BioGo team, Univ. Bordeaux, INSERM U1312, Bordeaux, France.; Department of Biochemistry and Molecular Biology, CHU Bordeaux, Bordeaux, France., Moreau-Gaudry F; Bordeaux Institute in Oncology - BRIC - BioGo team, Univ. Bordeaux, INSERM U1312, Bordeaux, France.; Department of Biochemistry and Molecular Biology, CHU Bordeaux, Bordeaux, France., Cappellen D; Bordeaux Institute in Oncology - BRIC - BioGo team, Univ. Bordeaux, INSERM U1312, Bordeaux, France.; Department of Tumor Biology and Tumor Library, CHU Bordeaux, Bordeaux, France., Dabernat S; Bordeaux Institute in Oncology - BRIC - BioGo team, Univ. Bordeaux, INSERM U1312, Bordeaux, France. sandrine.dabernat@u-bordeaux.fr.; Department of Biochemistry and Molecular Biology, CHU Bordeaux, Bordeaux, France. sandrine.dabernat@u-bordeaux.fr.
Publikováno v:
Journal of biological engineering [J Biol Eng] 2024 Oct 01; Vol. 18 (1), pp. 53. Date of Electronic Publication: 2024 Oct 01.
Autor:
Nokin MJ; University of Bordeaux, INSERM U1218, ACTION Laboratory, IECB, 33600 Pessac, France; Laboratory of Biology of Tumor and Development (LBTD), GIGA-Cancer, University of Liege, 4000 Liege, Belgium. Electronic address: mjnokin@uliege.be., Darbo E; Bordeaux Institute of Oncology (BRIC), INSERM U1312, University of Bordeaux, 33000 Bordeaux, France., Richard E; Bordeaux Institute of Oncology (BRIC), INSERM U1312, University of Bordeaux, 33000 Bordeaux, France., San José S; University of Bordeaux, INSERM U1218, ACTION Laboratory, IECB, 33600 Pessac, France; Centro de Investigación del Cáncer, CSIC-Universidad de Salamanca, 37007 Salamanca, Spain., de Hita S; University of Bordeaux, INSERM U1218, ACTION Laboratory, IECB, 33600 Pessac, France; Bordeaux Institute of Oncology (BRIC), INSERM U1312, University of Bordeaux, 33000 Bordeaux, France; Centro de Investigación del Cáncer, CSIC-Universidad de Salamanca, 37007 Salamanca, Spain., Prouzet-Mauleon V; Bordeaux Institute of Oncology (BRIC), INSERM U1312, University of Bordeaux, 33000 Bordeaux, France; CRISP'edit, TBMCore, University of Bordeaux, CNRS UAR 3427, INSERM US05, 33000 Bordeaux, France., Turcq B; Bordeaux Institute of Oncology (BRIC), INSERM U1312, University of Bordeaux, 33000 Bordeaux, France; CRISP'edit, TBMCore, University of Bordeaux, CNRS UAR 3427, INSERM US05, 33000 Bordeaux, France., Gerardelli L; Laboratory of Biology of Tumor and Development (LBTD), GIGA-Cancer, University of Liege, 4000 Liege, Belgium., Crake R; Laboratory of Biology of Tumor and Development (LBTD), GIGA-Cancer, University of Liege, 4000 Liege, Belgium., Velasco V; Department of Biopathology, Institut Bergonié, 33076 Bordeaux, France., Koopmansch B; Department of Human Genetics, University Hospital Center of Liege, 4000 Liege, Belgium., Lambert F; Department of Human Genetics, University Hospital Center of Liege, 4000 Liege, Belgium., Xue JY; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Sang B; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Horne J; Laboratory of Pharmaceutical Analytical Chemistry, CIRM, University of Liege, 4000 Liege, Belgium., Ziemons E; Laboratory of Pharmaceutical Analytical Chemistry, CIRM, University of Liege, 4000 Liege, Belgium., Villanueva A; Chemoresistance and Predictive Factors Group, Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO); Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet del Llobregat, 08908 Barcelona, Spain., Blomme A; Laboratory of Cancer Signaling, GIGA-Stem Cells, University of Liege, 4000 Liege, Belgium., Herfs M; Laboratory of Experimental Pathology, GIGA-Cancer, University of Liege, 4000 Liege, Belgium., Cataldo D; Laboratory of Biology of Tumor and Development (LBTD), GIGA-Cancer, University of Liege, 4000 Liege, Belgium., Calvayrac O; Cancer Research Centre of Toulouse, INSERM UMR1037, CNRS UMR5071, 31100 Toulouse, France., Porporato P; Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Torino, 10126 Torino, Italy., Nadal E; Molecular Mechanisms of Cancer Program, Department of Medical Oncology, Catalan Institute of Oncology (ICO), Preclinical and Experimental Research in Thoracic Tumors (PReTT) Group, Oncobell Program, IDIBELL, L'Hospitalet del Llobregat, 08908 Barcelona, Spain., Lito P; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Jänne PA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Ricciuti B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Awad MM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Ambrogio C; Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Torino, 10126 Torino, Italy. Electronic address: chiara.ambrogio@unito.it., Santamaría D; University of Bordeaux, INSERM U1218, ACTION Laboratory, IECB, 33600 Pessac, France; Centro de Investigación del Cáncer, CSIC-Universidad de Salamanca, 37007 Salamanca, Spain. Electronic address: d.santamaria@usal.es.
Publikováno v:
Cell reports. Medicine [Cell Rep Med] 2024 Aug 20; Vol. 5 (8), pp. 101663. Date of Electronic Publication: 2024 Aug 01.
Autor:
Loret C; University of Limoges, NeurIT UR 20218, GEIST Institute, F-87000 Limoges, France., Pauset A; University of Bordeaux, CRISP'edit, TBMCore UAR CNRS 3427, US Inserm 005, F-33000 Bordeaux, France.; University of Bordeaux, Modeling Transformation and Resistance in Leukemia, BRIC Inserm U1312, F-33000 Bordeaux, France., Faye PA; University of Limoges, NeurIT UR 20218, GEIST Institute, F-87000 Limoges, France.; CHU Limoges, Department of Biochemistry and Molecular Genetics, F-87000 Limoges, France., Prouzet-Mauleon V; University of Bordeaux, CRISP'edit, TBMCore UAR CNRS 3427, US Inserm 005, F-33000 Bordeaux, France.; University of Bordeaux, Modeling Transformation and Resistance in Leukemia, BRIC Inserm U1312, F-33000 Bordeaux, France., Pyromali I; University of Limoges, NeurIT UR 20218, GEIST Institute, F-87000 Limoges, France., Nizou A; University of Limoges, NeurIT UR 20218, GEIST Institute, F-87000 Limoges, France., Miressi F; University of Limoges, NeurIT UR 20218, GEIST Institute, F-87000 Limoges, France., Sturtz F; University of Limoges, NeurIT UR 20218, GEIST Institute, F-87000 Limoges, France.; CHU Limoges, Department of Biochemistry and Molecular Genetics, F-87000 Limoges, France., Favreau F; University of Limoges, NeurIT UR 20218, GEIST Institute, F-87000 Limoges, France.; CHU Limoges, Department of Biochemistry and Molecular Genetics, F-87000 Limoges, France., Turcq B; University of Bordeaux, CRISP'edit, TBMCore UAR CNRS 3427, US Inserm 005, F-33000 Bordeaux, France.; University of Bordeaux, Modeling Transformation and Resistance in Leukemia, BRIC Inserm U1312, F-33000 Bordeaux, France., Lia AS; University of Limoges, NeurIT UR 20218, GEIST Institute, F-87000 Limoges, France.; CHU Limoges, Department of Biochemistry and Molecular Genetics, F-87000 Limoges, France.; CHU Limoges, Department of Bioinformatics, F-87000 Limoges, France.
Publikováno v:
Biomedicines [Biomedicines] 2024 Jul 12; Vol. 12 (7). Date of Electronic Publication: 2024 Jul 12.
Autor:
Fontes, D., Cordeiro, R.C., Martins, G.S., Behling, H., Turcq, B., Sifeddine, A., Seoane, J.C.S., Moreira, L.S., Rodrigues, R.A.
Publikováno v:
In Quaternary Science Reviews 1 October 2017 173:161-180
Publikováno v:
In Palaeogeography, Palaeoclimatology, Palaeoecology 1 December 2014 415:175-182
Publikováno v:
In Palaeogeography, Palaeoclimatology, Palaeoecology 1 December 2014 415:105-116
Autor:
Moreira, L.S., Moreira-Turcq, P., Kim, J.H., Turcq, B., Cordeiro, R.C., Caquineau, S., Mandengo-Yogo, M., Sinninghe Damsté, J.S.
Publikováno v:
In Palaeogeography, Palaeoclimatology, Palaeoecology 1 December 2014 415:152-164